Concepedia

Publication | Open Access

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

DOIFull Paper Access

478

Citations

22

References

2021

Year

Alex C. Spyropoulos, Mark Goldin, Dimitrios Giannis, Wassim Diab, Janice Wang, Sameer Khanijo, Andrea Mignatti, Eugenia Gianos, Marc Cohen, Gulru Sharifova,
JAMA Internal Medicine

Abstract

ClinicalTrials.gov Identifier: NCT04401293.

References

YearCitations

Page 1